Hinge Health, Inc. logo HNGE - Hinge Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 13
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $65.82 DETAILS
HIGH: $95.00
LOW: $45.00
MEDIAN: $63.00
CONSENSUS: $65.82
UPSIDE: 19.13%
Annual Quarterly
Metric 2025 2024 2023
Revenue
Revenue 587.9 390.4 292.7
Cost of Revenue 118.6 89.8 98.6
Gross Profit 469.3 300.6 194.2
Operating Expenses
R&D Expenses 368.1 100.8 110.1
SG&A Expenses 639.4 227.5 214.6
Other Expenses 8.1 4.1 0
Operating Expenses 1,015.7 332.5 324.7
Operating Income
Operating Income (546.4) (31.9) (130.5)
Interest Expense 0 0 0
Interest Income 0 0 0
Profitability
EBITDA (535.9) (22.1) (128.4)
EBIT (541.0) (24.4) (130.5)
Income Before Tax (527.3) (11.3) (108.5)
Income Tax Expense 1.0 0.7 0.4
Net Income (528.3) (11.9) (108.1)
Per Share Data
EPS (Basic) -5.36 -0.15 -1.39
EPS (Diluted) -5.19 -0.15 -1.39
Shares Outstanding 79.2 78.0 78.0
Metric 2025 2024 2023
Current Assets
Cash & Cash Equivalents 208.0 300.8 235.0
Short-Term Investments 155.9 165.8 188.4
Net Receivables 66.1 42.5 46.6
Inventory 15.6 10.9 13.3
Other Current Assets 57.4 39.6 32.3
Total Current Assets 533.9 583.4 529.9
Non-Current Assets
Property, Plant & Equipment 17.4 17.0 22.5
Goodwill 64.1 61.6 61.6
Intangible Assets 2.5 1.8 2.2
Long-Term Investments 113.2 0 0
Other Non-Current Assets 13.7 9.4 6.4
Total Non-Current Assets 210.9 89.8 92.6
Total Assets 744.8 673.3 622.5
Current Liabilities
Account Payables 0 0 0
Short-Term Debt 0 0 0
Deferred Revenue 300.9 217.6 140.5
Other Current Liabilities 11.5 4.2 6.4
Total Current Liabilities 362.4 249.3 184.2
Non-Current Liabilities
Long-Term Debt 0 0 0
Deferred Tax Liabilities 0 0 0
Other Non-Current Liabilities 0 0 0
Total Non-Current Liabilities 3.8 7.3 11.1
Total Liabilities 366.2 256.6 195.2
Stockholders' Equity
Common Stock 0 0 0
Retained Earnings (1,051.0) (522.7) (510.8)
Accumulated Other Comprehensive Income (0.0) 0.1 0.1
Total Stockholders' Equity 378.5 416.7 427.3
Total Liabilities & Equity 744.8 673.3 622.5
Debt Metrics
Total Debt 8.0 11.1 15.7
Net Debt (200.0) (289.7) (219.2)
Metric 2025 2024 2023
Operating Activities
Net Income (528.3) (11.9) (108.1)
Depreciation & Amortization 5.5 6.0 5.6
Stock-Based Compensation 643.0 0.7 1.6
Change in Working Capital (2.0) 13.5 9.4
Other Non-Cash Items 53.2 41.3 28.0
Operating Cash Flow 171.4 49.0 (63.9)
Investing Activities
Capital Expenditure (0.7) (3.8) (4.6)
Acquisitions (4) 0 0
Purchases of Investments (472.3) (324.5) (453.3)
Sales/Maturities of Investments 368.6 346.6 459.5
Other Investing Activities (5.4) (2.7) (2.6)
Investing Cash Flow (113.8) 18.3 1.5
Financing Activities
Net Debt Issuance 0 0 0
Stock Repurchased (65.0) 0 0
Dividends Paid 0 0 0
Other Financing Activities (350.6) (2.8) (3)
Financing Cash Flow (150.5) (2.2) (3)
Cash Position
Net Change in Cash (92.8) 65.1 (65.4)
Cash at Beginning 302.6 237.5 302.9
Cash at End 209.8 302.6 237.5
Free Cash Flow 170.7 45.2 (68.5)
Key Metrics 2025 2024 2023
Income Statement
Revenue 587.9 390.4 292.7
Gross Profit 469.3 300.6 194.2
Operating Income (546.4) (31.9) (130.5)
Net Income (528.3) (11.9) (108.1)
EPS (Diluted) -5.19 -0.15 -1.39
Balance Sheet
Cash & Equivalents 208.0 300.8 235.0
Total Assets 744.8 673.3 622.5
Total Debt 8.0 11.1 15.7
Stockholders' Equity 378.5 416.7 427.3
Cash Flow
Operating Cash Flow 171.4 49.0 (63.9)
Capital Expenditure (0.7) (3.8) (4.6)
Free Cash Flow 170.7 45.2 (68.5)